Search “Semax dosage” and you’ll get an answer within three clicks, usually a number in micrograms, usually stated like it came from a lab printout. It didn’t. Here is the problem: no controlled human trial has ever established a dosing schedule for the reason most people are taking this thing, which is cognitive focus in a healthy adult. Read that sentence again, because it’s the whole article. What follows is not a bigger, better number to replace the one you found. It’s why that number doesn’t exist, and what to do instead.
The one honest data point
Buried in the human literature is a single figure worth trusting, because it comes from an actual clinical protocol rather than a forum thread. A study of 110 ischemic stroke patients used 6,000 micrograms of Semax per day for ten days, in a defined course, under medical supervision, and tracked plasma BDNF alongside daily-functioning scores [2]. That’s a real number. It’s also a hospital dose for stroke rehab, published in Russian, non-randomized, and about as transferable to a healthy person spraying focus juice before a Tuesday meeting as an ICU insulin drip is to a diabetic skipping dessert. One data point. Zero generalization rights.
Everything else circulating online traces back to either animal studies dosed by body weight in a lab, or to numbers with no study behind them at all.
What Semax actually is, in one paragraph
Semax is a seven-amino-acid peptide (Met-Glu-His-Phe-Pro-Gly-Pro), an analog of an ACTH fragment first written up in 1991 [4]. Russia has it on its official List of Vital and Essential Drugs, prescribed for stroke and cognitive complaints [5]. The US has no FDA approval for it, period. It’s taken as a nasal spray, micrograms at a time, usually multiple times a day. That last detail matters more than the peptide chemistry: you’re not swallowing a pill with a wide margin for error. You’re dosing something active across nasal tissue, repeatedly, at a scale where small errors compound fast.
Ranking the four things people call “dosing,” worst evidence to best
Strip away the marketing language and “what’s the dose” is actually four separate questions. Ranked here from thinnest evidence to thickest, because that ranking tells you where to be most careful.
4. Amount per spray, for a healthy adult. No controlled human dose-response data exists for this use, full stop. The animal work is genuinely solid, a 2006 rat study in Brain Research gave 50 micrograms per kilogram and measured roughly a 1.4-fold rise in hippocampal BDNF [1], and a 2020 rat study in Genes showed a shift toward neurotransmission genes after simulated stroke [3]. Real science. Rats. Body-weight dosing. Zero bridge to a human microgram figure for enhancement use.
3. Frequency. Semax is short-acting, so protocols involve repeat daily dosing rather than one shot. How many times, spaced how far apart, for you specifically? Nobody’s run that trial in non-patients either.
2. Duration. The Russian clinical model runs defined courses for defined conditions [5], not indefinite daily use. There is no long-term safety data for open-ended dosing, which is not a neutral gap, it’s a reason for caution, not a green light.
1. Whether the bottle contains what the label says. This ranks highest because, unlike the other three, it’s not a question of missing research, it’s a question of accountability, and it’s fully answerable right now. A microgram-scale spray with the wrong concentration doesn’t just underperform, it makes every other decision on this list meaningless.
See also: How Wearables Are Revolutionizing Personal Fitness
The “just take more” instinct, and why it’s backwards
Nobody has mapped a dose-response curve for this compound in healthy people. That means “it’s not working, I’ll double it” isn’t a tweak. It’s an experiment with no comparison group, no monitoring, and no data telling you whether more helps, does nothing, or does something the thin evidence base can’t characterize. Russian clinical use runs fixed courses, not self-escalating ones [5]. If a regimen isn’t delivering, the correct move is a conversation with a clinician about the dose, the compound, or the goal, not a quiet decision to push the amount yourself.
The sourcing question hiding inside the dosing question
Here’s the part dosing guides tend to skip. A microgram dose only means something if the liquid matches the label, and at that scale you cannot verify it by looking, tasting, or feeling anything. You’re trusting the manufacturer, full stop.
That splits the market in two. Research-chemical sellers ship product marked “for research use only,” which is the legal basis for the sale, not a safety claim. No clinician is involved. No prescription exists. No regulator checks whether the bottle matches its own paperwork. Any certificate on the page is the seller grading its own homework.
The supervised route works differently: a licensed clinician evaluates you, writes a prescription when appropriate, and a licensed compounding pharmacy prepares the product, accountable to a regulator for identity and strength. FormBlends is one provider running that model, Semax reaching you through clinician oversight and a licensed pharmacy instead of a plain envelope with a research-use disclaimer stapled to it. Nothing here is for sale on this page, there’s no checkout, just a description of how the accountable version of this process works. For a compound dosed in micrograms, that accountability isn’t decoration. It’s the entire reason the dose you take matches the dose you intended.
If you go the supervised route, log it
Keep a written record: date, amount, anything you noticed, good or bad. It sounds unglamorous and it’s the single habit that turns a follow-up appointment into a data conversation instead of a memory test. A notebook does the job. If you want something built for it, the FormBlends tracker app exists purely to log dose and symptoms over time. Again, not a purchase, just a tool. Research-chemical orders end the moment they ship. The supervised route gives you a follow-up loop, and a log is what makes that loop useful.
Where this leaves you
You wanted a number. The research gives you a ranked list of decisions instead, and one honest data point buried inside a stroke-rehab study that doesn’t transfer to you. The mechanism is real, demonstrated in rats twice over [1][3]. The human evidence is real too, but narrow, non-randomized, and drawn from supervised patients, not people self-dosing for focus [2]. Everything downstream of that, the amount, the frequency, the duration, and whether the bottle is honest, is a clinical decision, not a forum consensus. Put a licensed clinician between yourself and the spray bottle. Write things down once you start. That’s what the data actually supports, and it’s a shorter list than the one the sales pages are selling you.
What people usually want to know
What is the standard Semax dose in micrograms? There isn’t one, not for general or cognitive use anyway. The published clinical dose comes from supervised Russian stroke care: 6,000 micrograms per day for ten days, in a defined course with a gap between courses, in hospitalized patients [2]. That’s a hospital protocol for a specific condition, not a self-dosing recommendation, and it doesn’t transfer to healthy daily use.
Why doesn’t the research give a clear dose for healthy people? Because nobody has run the controlled human dose-response study in healthy people. The strongest mechanistic data is in rats, dosed by body weight, such as the 2006 Brain Research study using 50 micrograms per kilogram and finding a roughly 1.4-fold rise in hippocampal BDNF [1]. That establishes a plausible mechanism. It does not hand you a microgram figure for a human nose.
Is Semax FDA-approved? No. Not for anything, in the US. It’s a registered prescription drug in Russia, listed on that country’s List of Vital and Essential Drugs for stroke and cognitive complaints [5], but Russian registration carries zero weight with the FDA.
Why does dosing accuracy matter more for a nasal peptide than a pill? Because you’re dealing in micrograms delivered across nasal tissue, often several times a day, not a tablet with a comfortable safety margin. You cannot see, taste, or feel whether the concentration in the bottle matches the label. That gap between intended dose and actual dose depends entirely on whether the manufacturer is accountable for what they made.
Is research-chemical Semax the same as a prescription version? Not verifiably. “Research use only” is the legal basis for that sale, not a quality claim, and it means no clinician evaluation, no prescription, no regulator checking the bottle against its paperwork. A certificate on a vendor page is the seller vouching for itself. A supervised route puts a licensed clinician and a regulator-accountable compounding pharmacy in between.
Should I raise the dose if Semax isn’t working? Not on your own. There’s no controlled human dose-response curve for non-stroke use, so increasing the amount is an experiment with no data behind it, and Russian clinical practice runs fixed courses rather than open-ended escalation [5]. If it’s not doing what you hoped, that’s a conversation for a clinician, not a decision for you alone.
What is Semax and where does it come from?
Semax is a synthetic peptide built from a fragment of ACTH, a hormone your pituitary already makes. Russian researchers developed it in the 1980s, and it’s used clinically in Russia and Ukraine for stroke recovery and cognitive complaints. Outside those countries it carries no regulatory approval, so in the US it sits in a legal grey zone worth understanding before you buy anything.
What does Semax actually do in the brain?
It appears to raise BDNF, a protein tied to neuron survival and plasticity, and may touch dopamine and serotonin activity too. Animal work and some small human studies point to effects on attention, memory consolidation, and neuroprotection after stroke-type injury. The catch: most of the human data comes from Russian clinical literature that’s hard to independently verify, so confident claims about cognitive enhancement in healthy people are running ahead of what’s actually been shown.
How many mg of Semax a day do researchers typically use?
Published Russian protocols generally sit between 0.1 mg and 1 mg per day, intranasal, in short courses of one to two weeks rather than continuous use. Self-experimenters online report similar ranges, but there’s no established optimal dose for healthy adults, and individual response varies. Going through a physician-supervised compounding pharmacy like FormBlends means a prescriber sets that number for your situation instead of you guessing from a screenshot.
What is Semax peptide most commonly used for by people who take it?
Mostly focus, mental clarity under stress, and mood stability, off-label cognitive use with a thin evidence trail. The strongest documented case is post-stroke rehab, where some controlled work shows real benefit. For healthy people chasing a mental edge, the evidence thins out fast into anecdote. Worth sitting with that gap before you spend money on it.
References
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006;1117(1):54-60. PMID: 16996037.
- Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018;118(3-2):61-68. PMID: 29798983.
- Filippenkov IB, Stavchansky VV, Denisova AE, et al. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats. Genes (Basel). 2020;11(6):681. PMID: 32580520.
- Potaman VN, Alfeeva LY, Kamensky AA, Levitzkaya NG, Nezavibatko VN. N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes. Biochemical and Biophysical Research Communications. 1991;176(2):741-746. PMID: 1851003.
- Government of the Russian Federation. List of Vital and Essential Medicines (Perechen zhiznenno neobkhodimykh i vazhneishikh lekarstvennykh preparatov). Semax included as a registered prescription drug.
